Journal of Psychosomatic Research
Volume 64, Issue 6 , Pages 567-572 , June 2008

Multidimensionality of symptom complexes in irritable bowel syndrome and other functional gastrointestinal disorders

Received 3 September 2007 ,Revised 21 January 2008 ,Accepted 7 February 2008.

References 

  1. Drossman DA, Corazziari E, Delvaux M, et al, editors. Rome III: the functional gastrointestinal disorders. 3rd ed. McLean (Va): Degnon Associates, Inc. pp. 487–509, 2006.
  2. Committee on Nomenclature of the American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed.: DSM-IV, American Psychiatric Association, Arlington, VA, 1995.
  3. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology. 2002;122:1140–1156
  4. Whitehead WE, Palsson OS, Levy RL, Von Korff M, Feld AD, Turner MJ. Comorbid psychiatric disorders in irritable bowel (IBS) and inflammatory bowel disease (IBD). Gastroenterology. 2003;124(Suppl 1):A–398
  5. Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M. How many functional somatic syndromes?. J Psychosom Res. 2001;51:549–557
  6. Miller AR, North CS, Clouse RE, Wetzel RD, Spitznagel EL, Alpers DH. The association of irritable bowel syndrome and somatization disorder. Ann Clin Psychiatry. 2001;13:25–30
  7. Robbins JM, Kirmayer LJ, Hemami S. Latent variable models of functional somatic distress. J Nerv Ment Dis. 1997;85:606–615
  8. Hamelsky SW, Lipton RB. Psychiatric comorbidity of migraine. Headache. 2006;46:1327–1333
  9. Aggarwal VR, McBeth J, Zakrzewska JM, Lunt M, Macfarlane GJ. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?. Int J Epidemiol. 2006;35:468–476
  10. Bittner AC, Croffut RM, Stranahan MC. Prescript–assist probiotic–prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study. Clin Ther. 2005;27:755–761
  11. Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003;98:2454–2459
  12. Schur EA, Afari N, Furberg H, Olarte M, Goldberg J, Sullivan PF, et al. Feeling bad in more ways than one: comorbidity patterns of medically unexplained and psychiatric conditions. J Gen Intern Med. 2007;22:818–821
  13. Jones R, Latinovic R, Charlton J, Gulliford M. Physical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the General Practice Research Database. Aliment Pharmacol Ther. 2006;24:879–886
  14. Mearin F, Baro E, Roset M, Badia X, Zarate N, Perez I. Clinical patterns over time in irritable bowel syndrome: symptom instability and severe variability. Am J Gastroenterol. 2004;99:113–121
  15. Bond B, Quinlan J, Clouse RE, Dukes GE, Alpers DH. Evaluation of the natural history of irritable bowel syndrome requires attention to multiple domains, not just bowel habits and abdominal pain. Unpublished observations.
  16. Lackner JM, Gudleski GD, Zack MM, Katz LA, Powell C, Krasner S, et al. Measuring health-related quality of life in patients with irritable bowel syndrome: can less be more?. Psychosom Med. 2006;68:312–320
  17. Hulisz D. The burden of illness of irritable bowel syndrome: current challenges and hope for the future. J Manag Care Pharm. 2004;10:299–309
  18. Lipowski ZJ. Somatization: the concept and its clinical application. Am J Psychiatry. 1988;145:1358–1368
  19. North CS, Alpers DH, Thompson SJ, Spitznagel EL. Gastrointestinal symptoms and psychiatric disorders in the general population. Findings from NIMH Epidemiologic Catchment Area Project. Dig Dis Sci. 1996;41:633–640
  20. Wetzel RD, Guze SB, Cloninger CR, Martin RL, Clayton PJ. Briquet's syndrome (hysteria) is both a somatoform and a “psychoform” illness: a Minnesota Multiphasic Personality Inventory study. Psychosom Med. 1994;56:564–569
  21. North CS, Downs D, Clouse RE, Alrakawi A, Dokucu ME, Cox J, et al. The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol. 2004;2:787–795
  22. Simon GE, Gureje O. Stability of somatization disorder and somatization symptoms among primary care patients. Arch Gen Psychiatry. 1999;56:90–95
  23. Katon W, Lin E, Von Korff M, Russo J, Lipscomb P, Bush T. Somatization: a spectrum of severity. Am J Psychiatry. 1998;173:198–202
  24. North CS. Somatization in survivors of catastrophic trauma: a methodological review. Environ Health Perspect. 2002;110(Suppl 4):637–640
  25. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994;272:1749–1756
  26. Kroenke K, Spitzer RL, deGruy FV, Swindle R. A symptom checklist to screen for somatoform disorders in primary care. Psychosomatics. 1998;39:263–272
  27. Brown WH, Chey WD, Elta GH. Number of responses on a review of systems questionnaire predicts the diagnosis of functional gastrointestinal disorders. J Clin Gastroenterol. 2003;36:222–227
  28. Sayuk GS, Elwing JE, Lustman PJ, Clouse RE. Anxiety and depression predict the likelihood of functional GI disorders (FGID) separately from their relationship to somatization. Gastroenterology. 2006;130(Suppl 2):A–92
  29. Henningsen P, Herzog W. Irritable bowel syndrome and somatoform disorders. J Psychosom Res. 2008;64:
  30. Riedl A, Schmidtmann M, Stengel A, Goebel M, Klapp BF, Monnikes H. Somatic comorbidities of the irritable bowel syndrome—a systematic analysis. J Psychosom Res. 2008;64:
  31. Creed F, Tomenson B, Guthrie E, Ratcliffe J, Fernandes L, Read N, et al. The relationship between somatisation and outcome in patients with severe irritable bowel syndrome. J Psychosom Res. 2008;64:
  32. Enck P, Klosterhalfen S, Zipfel S, Martens U. Irritable bowel syndrome: a single gastrointestinal disease or a general somatoform disorder?. J Psychosom Res. 2008;64:
  33. Lembo A, Ameen VE, Drossman DA. Irritable bowel syndrome: toward an understanding of severity. Clin Gastroenterol Hepatol. 2005;3:717–725
  34. Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007;5:534–540
  35. Drossman DA, Li Z, Toner BB, Diamant NE, Creed FH, Thompson D, et al Functional bowel disorders. A multicenter comparison of health status and development of illness severity index. Dig Dis Sci. 1995;40:986–995
  36. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395–402
  37. Svedlund J, Sjodin I, Dotevall G. GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129–134

PII: S0022-3999(08)00059-7

doi: 10.1016/j.jpsychores.2008.02.023

Journal of Psychosomatic Research
Volume 64, Issue 6 , Pages 567-572 , June 2008

Article Tools